| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8769723 | American Journal of Kidney Diseases | 2018 | 12 Pages |
Abstract
Omega-3 PUFA supplementation probably protects against primary loss of arteriovenous access patency, but may have little or no effect on dialysis suitability failure, access interventions or access abandonment. Potential treatment harms are uncertain.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Andrea K. Viecelli, Ashley B. Irish, Kevan R. Polkinghorne, Carmel M. Hawley, David W. Johnson, Trevor A. Mori, Elaine M. Pascoe, Giovanni F.M. Strippoli, Charmaine E. Lok, Suetonia C. Palmer,